Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. lists 62 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 50419-250 | Adempas Tablet, Film Coated | Riociguat .5 mg/1 | Rx |
| 50419-251 | Adempas Tablet, Film Coated | Riociguat 1 mg/1 | Rx |
| 50419-252 | Adempas Tablet, Film Coated | Riociguat 1.5 mg/1 | Rx |
| 50419-253 | Adempas Tablet, Film Coated | Riociguat 2 mg/1 | Rx |
| 50419-254 | Adempas Tablet, Film Coated | Riociguat 2.5 mg/1 | Rx |
| 50419-322 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-330 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-329 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-328 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-327 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-326 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-331 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-324 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-323 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-321 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-332 | Ambelvist Injection | Gadoquatrane 257.9 mg/mL | Rx |
| 50419-483 | Angeliq Tablet, Film Coated | Estradiol 1 mg/1; Drospirenone .5 mg/1 | Rx |
| 50419-482 | Angeliq Tablet, Film Coated | Estradiol .5 mg/1; Drospirenone .25 mg/1 | Rx |
| 50419-524 | Betaseron Kit | Rx | |
| 50419-407 | Beyaz Kit | Rx | |
| 50419-747 | Biltricide Tablet, Film Coated | Praziquantel 600 mg/1 | Rx |
| 50419-777 | Cipro Kit | Rx | |
| 50419-758 | Cipro Tablet, Film Coated | Ciprofloxacin Hydrochloride 250 mg/1 | Rx |
| 50419-773 | Cipro Kit | Rx | |
| 50419-754 | Cipro Tablet, Film Coated | Ciprofloxacin Hydrochloride 500 mg/1 | Rx |
| 50419-452 | Climara Patch | Estradiol .1 mg/d | Rx |
| 50419-451 | Climara Patch | Estradiol .05 mg/d | Rx |
| 50419-453 | Climara Patch | Estradiol .075 mg/d | Rx |
| 50419-454 | Climara Patch | Estradiol .025 mg/d | Rx |
| 50419-456 | Climara Patch | Estradiol .0375 mg/d | Rx |
| 50419-459 | Climara Patch | Estradiol .06 mg/d | Rx |
| 50419-491 | Climara Pro Patch | Estradiol .045 mg/d; Levonorgestrel .015 mg/d | Rx |
| 50419-320 | Eovist Injection, Solution | Gadoxetate Disodium 181.43 mg/mL | Rx |
| 50419-325 | Gadavist Injection | Gadobutrol 604.72 mg/mL | Rx |
| 50419-397 | Hyrnuo Tablet, Film Coated | Sevabertinib 10 mg/1 | Rx |
| 50419-540 | Kerendia Tablet, Film Coated | Finerenone 10 mg/1 | Rx |
| 50419-541 | Kerendia Tablet, Film Coated | Finerenone 20 mg/1 | Rx |
| 50419-542 | Kerendia Tablet | Finerenone 40 mg/1 | Rx |
| 50419-424 | Kyleena Intrauterine Device | Levonorgestrel 19.5 mg/1 | Rx |
| 50419-750 | Lampit Tablet, Film Coated | Nifurtimox 30 mg/1 | Rx |
| 50419-751 | Lampit Tablet, Film Coated | Nifurtimox 120 mg/1 | Rx |
| 50419-475 | Lynkuet Capsule | Elinzanetant 60 mg/1 | Rx |
| 50419-455 | Menostar Patch | Estradiol 14 ug/d | Rx |
| 50419-423 | Mirena Intrauterine Device | Levonorgestrel 52 mg/1 | Rx |
| 50419-409 | Natazia Kit | Rx | |
| 50419-489 | Nexavar Tablet, Film Coated | Sorafenib 200 mg/1 | Rx |
| 50419-488 | Nexavar Tablet, Film Coated | Sorafenib 200 mg/1 | Rx |
| 50419-395 | Nubeqa Tablet, Film Coated | Darolutamide 300 mg/1 | Rx |
| 50419-403 | Safyral Kit | Rx | |
| 50419-422 | Skyla Intrauterine Device | Levonorgestrel 13.5 mg/1 | Rx |
| 50419-171 | Stivarga Tablet, Film Coated | Regorafenib 40 mg/1 | Rx |
| 50419-348 | Ultravist Injection | Iopromide 370 mg/mL | Rx |
| 50419-347 | Ultravist Injection | Iopromide 300 mg/mL | Rx |
| 50419-346 | Ultravist Injection | Iopromide 370 mg/mL | Rx |
| 50419-344 | Ultravist Injection | Iopromide 300 mg/mL | Rx |
| 50419-393 | Vitrakvi Solution, Concentrate | Larotrectinib 20 mg/mL | Rx |
| 50419-392 | Vitrakvi Solution, Concentrate | Larotrectinib 20 mg/mL | Rx |
| 50419-391 | Vitrakvi Capsule | Larotrectinib 100 mg/1 | Rx |
| 50419-390 | Vitrakvi Capsule | Larotrectinib 25 mg/1 | Rx |
| 50419-208 | Xofigo Injection | Radium Ra-223 Dichloride 30 uCi/mL | Rx |
| 50419-402 | Yasmin Kit | Rx | |
| 50419-405 | Yaz Kit | Rx |
Recalls by Bayer HealthCare Pharmaceuticals Inc.
- D-0145-2024 Dec 6, 2023 · Class I
Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing - D-0254-2022 Nov 24, 2021 · Class II
cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0253-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0252-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0251-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0250-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0249-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0248-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0247-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0246-2022 Nov 24, 2021 · Class I
Chemical Contamination: presence of benzene - D-0245-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0244-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0243-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0242-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0241-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0240-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0239-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0238-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0237-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene. - D-0236-2022 Nov 24, 2021 · Class II
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.